The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.
Derrick McVicker
Advertisement
Derrick McVicker, PhD, is group leader at PPD Laboratories’ GMP cell lab.
Articles by Derrick McVicker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Nuravax Alzheimer Vaccine AV-1959R Earns FDA Fast Track Designation
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
The BioPharm Brief: Lung Injury Survival, Alzheimer Prevention, and Longer Dosing Intervals
4
METiS TechBio, Lilly Partner on AI-Designed LNPs for Tissue-Specific Delivery
5